BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Midde NM, Sinha N, Lukka PB, Meibohm B, Kumar S. Alterations in cellular pharmacokinetics and pharmacodynamics of elvitegravir in response to ethanol exposure in HIV-1 infected monocytic (U1) cells. PLoS One 2017;12:e0172628. [PMID: 28231276 DOI: 10.1371/journal.pone.0172628] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Cattaneo D, Cossu MV, Rizzardini G. Pharmacokinetic drug evaluation of ritonavir (versus cobicistat) as adjunctive therapy in the treatment of HIV. Expert Opin Drug Metab Toxicol 2019;15:927-35. [PMID: 31668105 DOI: 10.1080/17425255.2019.1685495] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Gong Y, Rao PSS, Sinha N, Ranjit S, Cory TJ, Kumar S. The role of cytochrome P450 2E1 on ethanol-mediated oxidative stress and HIV replication in human monocyte-derived macrophages. Biochem Biophys Rep 2019;17:65-70. [PMID: 30582009 DOI: 10.1016/j.bbrep.2018.11.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Agas A, Kalluru J, Leiser B, Garcia R, Kataru H, Haorah J. Possible mechanisms of HIV neuro-infection in alcohol use: Interplay of oxidative stress, inflammation, and energy interruption. Alcohol 2021;94:25-41. [PMID: 33864851 DOI: 10.1016/j.alcohol.2021.04.003] [Reference Citation Analysis]
4 Kodidela S, Kumar S. Choosing the right pharmacotherapeutic strategy for HIV maintenance in patients with alcohol addiction. Expert Opin Pharmacother 2019;20:631-3. [PMID: 30724618 DOI: 10.1080/14656566.2019.1574748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Molina PE, Simon L, Amedee AM, Welsh DA, Ferguson TF. Impact of Alcohol on HIV Disease Pathogenesis, Comorbidities and Aging: Integrating Preclinical and Clinical Findings. Alcohol Alcohol 2018;53:439-47. [PMID: 29546271 DOI: 10.1093/alcalc/agy016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
6 Rahman MA, Gong Y, Kumar S. In vitro evaluation of structural analogs of diallyl sulfide as novel CYP2E1 inhibitors for their protective effect against xenobiotic-induced toxicity and HIV replication. Toxicol Lett 2018;292:31-8. [PMID: 29694836 DOI: 10.1016/j.toxlet.2018.04.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
7 Rahman MA, Patters BJ, Kodidela S, Kumar S. Extracellular Vesicles: Intercellular Mediators in Alcohol-Induced Pathologies. J Neuroimmune Pharmacol 2020;15:409-21. [PMID: 30955131 DOI: 10.1007/s11481-019-09848-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
8 Midde NM, Gong Y, Cory TJ, Li J, Meibohm B, Li W, Kumar S. Influence of Ethanol on Darunavir Hepatic Clearance and Intracellular PK/PD in HIV-Infected Monocytes, and CYP3A4-Darunavir Interactions Using Inhibition and in Silico Binding Studies. Pharm Res 2017;34:1925-33. [PMID: 28616684 DOI: 10.1007/s11095-017-2203-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Downen JM, Swendener B, Bodlak AA, Añazco DF, Nicolalde BI, Mhaskar R, Cevallos N, Castillo A, Larreategui D, Torres E, Izurieta R, Teran E. Quantifying alcohol use among Ecuadorian human immunodeficiency virus positive individuals and assessing alcohol as an independent risk factor for human immunodeficiency virus: A case control study STROBE. Medicine (Baltimore) 2020;99:e23276. [PMID: 33235085 DOI: 10.1097/MD.0000000000023276] [Reference Citation Analysis]
10 Lesko CR, Nance RM, Lau B, Fojo AT, Hutton HE, Delaney JAC, Crane HM, Cropsey KL, Mayer KH, Napravnik S, Geng E, Mathews WC, McCaul ME, Chander G; CNICS. Changing Patterns of Alcohol Use and Probability of Unsuppressed Viral Load Among Treated Patients with HIV Engaged in Routine Care in the United States. AIDS Behav 2021;25:1072-82. [PMID: 33064249 DOI: 10.1007/s10461-020-03065-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Desai N, Burns L, Gong Y, Zhi K, Kumar A, Summers N, Kumar S, Cory TJ. An update on drug-drug interactions between antiretroviral therapies and drugs of abuse in HIV systems. Expert Opin Drug Metab Toxicol 2020;16:1005-18. [PMID: 32842791 DOI: 10.1080/17425255.2020.1814737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]